Michael S. Wyzga, Director at X4 Pharmaceuticals, Inc (XFOR), bought 25,000 shares at $1.20 ($30K) on 2023-08-18, disclosed to the SEC on 2023-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EXAS | SELL | 2019-03-01 | $48K | — | Filing → |
| EXAS | SELL | 2018-08-30 | $369K | — | Filing → |
| EXAS | SELL | 2018-05-11 | $763K | — | Filing → |